// App-Quantinova.ai

50 : Long-Term Efficacy and Safety of Tocilizumab (TCZ) Monotherapy in Patients (PTS) with Rheumatoid Arthritis (RA) Previously Methotrexate (MTX) Naive or MTX Free for 6 Months Prior to Study Start

Researchers

Presenter

  • Anthony Sebba

Principal Investigators

  • Andrew Anisfeld

  • Jenny Devenport

  • Corrado Bernasconi

  • Devi Smart

  • Daniel Galindez

  • Chiedzo Mpofu

  • Juan Gomez-Reino

  • Graeme Jones

Medical Centers

  • NL Research Technologies NLRT, St. John's, NF, Canada

  • University of Tasmania, Hobart, Australia

Locations

  • Canada

  • Australia

Companies

  • F. Hoffmann-La Roche

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

  • Tocilizumab

Outcome

  • Unknown

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved